| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.7M | +8.1% | +9.8% |
| Cost of Revenue | $1.9M | -9.4% | -13.8% |
| Gross Profit | $12.8M | +11.4% | +14.6% |
| R&D Expense | $3.1M | +27.4% | +25.6% |
| SG&A Expense | $21.9M | -6.3% | +1.1% |
| Operating Income | -$12.3M | +14.7% | +5.7% |
| Pre-tax Income | -$12.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $85.1M | -10.4% | -15.0% |
| Accounts Receivable | $8.2M | +14.8% | -9.1% |
| Inventory | $11.4M | -2.8% | -4.2% |
| Current Assets | $107.9M | -7.1% | -12.9% |
| Total Assets | $111.3M | -6.9% | -12.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.4M | — | — |
| Capital Expenditures | $512K | — | — |
| Investing Cash Flow | -$512K | — | — |
| Financing Cash Flow | $10.1M | — | — |
| Free Cash Flow | -$30.9M | — | — |
| +12.7% |
| +1.4% |
| Income Tax | -$3K | +0.0% | -106.4% |
| Net Income | -$12.9M | +12.7% | +1.7% |
| EPS (Basic) | -$0.49 | +14.0% | +14.0% |
| EPS (Diluted) | -$0.49 | +14.0% | +14.0% |
| $11.2M |
| +15.8% |
| +2.5% |
| Long-term Debt | $49.5M | +0.1% | +0.5% |
| Total Liabilities | $63.3M | +2.7% | +1.2% |
| Stockholders' Equity | $48.1M | -17.1% | -26.3% |